Retinoic Acid and Vitamin E Modulate Expression and Release of CD178 in Carcinoma Cells: Consequences for Induction of Apoptosis in CD95-Sensitive Cells

This publication has 40 references indexed in Scilit:

• Differential Activity of Soluble versus Cellular Fas Ligand: Regulation by an Accessory Molecule
  Cellular Immunology, 1999
• FAS(CD95) ligand expression by tumor cell variants can be unrelated to their capacity to induce tolerance or immune rejection
  International Journal of Cancer, 1999
• Induction of apoptosis by IFNγ in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit
  Cell Death & Differentiation, 1999
• Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes.
  Journal of Clinical Investigation, 1998
• Regulation of RARβ expression by RAR- and RXR-selective retinoids in human lung cancer cell lines: Effect on growth inhibition and apoptosis induction
  International Journal of Cancer, 1998
• Regulation of CD95 (Apo-1/Fas) Ligand and Receptor Expression in Human Embryonal Carcinoma Cells by Interferon γ and all-trans Retinoic Acid
  Biological Chemistry, 1998
• Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells
  Molecular Carcinogenesis, 1997
• Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes
  Nature, 1996
• Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
  Science, 1995
• Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors
  Cell, 1991